E-resources
-
Fathimath Farah Shiham
Thorax, 05/2021, Volume: 76, Issue: 5Journal Article
Correspondence to Dr Fathimath Farah Shiham, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK; farah.shiham@doctors.org.uk Convalescent plasma treatment of severe COVID-19: potential benefit but many unanswered questions Virus-specific antibodies in convalescent plasma have demonstrated a therapeutic benefit in viral infections such as SARS and may offer similar potential in COVID-19 infection. Liu and colleagues (Nat Med 2020;26:1708) conducted a retrospective propensity score matched control study to evaluate the effectiveness of convalescent plasma therapy in 39 patients with severe or life-threatening COVID-19 within 14 days of symptom onset. For safety reasons, older participants were vaccinated after the 18–55 cohort and hence only 5 cases of COVID-19 had occurred in participants older than 55 at data lock; therefore, vaccine efficacy in this age group could not be assessed.
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.